A randomized clinical trial of oral steroids for ulnar neuropathy in type 1 and type 2 leprosy reactions

Arquivos de Neuro-Psiquiatria

Volumn 66, Issue 4, 2008, Pages 861-867

  Garbino, José Antonio ^a   Virmond, Marcos Da Cunha Lopes ^b   Ura, Somei ^a   Salgado, Manoel Henrique ^b   Naafs, Bernard ^c  

^a INSTITUTO LAURO DE SOUZA LIMA   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Leprosy; Neurophysiology; Steroids; Ulnar neuropathy

Indexed keywords

PREDNISONE;

ARTICLE; CONTROLLED STUDY; CUBITAL TUNNEL SYNDROME; HUMAN; LEPROSY; MAJOR CLINICAL STUDY; MOTOR NERVE CONDUCTION; MUSCLE FUNCTION; NEUROPHYSIOLOGY; PAIN; PALPATION; SCORING SYSTEM; SENSORY SYSTEM; STUDENT T TEST; ULNAR NERVE;

EID: 58149237457     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2008000600016     Document Type: Article

References (29)

1. Riddley DS, Jopling WH. Classification of leprosy according to immunity: a five group system. Int J Lepr Other Mycobact Dis 1966;34:255-273.
2. Rose P, Waters MFR. Reversal reaction in leprosy and their management. Lepr Rev 1991;62:113-121.
3. Lockwood DNJ, Vinayakumar S, Stanley JNA, McAdam KPWJ, Colston MJ. Clinical features and outcome of reversal (type 1) reactions in Hyderabad, India. Int J Lepr 1993;61:8-15.
4. Wilder-Smith A, Wilder-Smith E. Effect of steroid therapy on parameters of peripheral autonomic dysfunction in leprosy patients with acute neuritis. Int J Lepr 1997;65:20-27.
5. Srinivasan H, Rao KS, Shanmugam N. Steroid therapy in recent "quiet nerve paralysis" in leprosy. Lepr India 1982;54:412-419.
6. Thacker AK, Chandra S, Mukhija RD, Sarkari NB. Electro-physiological evaluation of nerves during reactions in leprosy. J Neurol 1996;243: 530-535.
7. Sugumaran ST. Steroid therapy for paralytic deformities in leprosy. Int. J Lepr 1997;65:337-344.
8. Roche PW, Theuvenet J, LE Master J W, Butlin C R. Contribution of type 1 reaction to sensory and motor function loss in borderline leprosy patients and the efficacy of treatment with prednisone. Int J Lepr 1998;66: 340-347.
9. Manandhar R, Shrestha N, Butlin CR, Roche PW. High levels of inflammatory cytokines are associated with poor clinical response to steroid treatment and recurrent episodes of type 1 reactions in leprosy. Clin Exp Immunol 2002;128:333-338.
10. van Brakel WH, Anderson AM, Withington SG, et al. The prognostic importance of detecting mild sensory impairment in leprosy: a randomized controlled trial (TRIPOD 2). Lepr Rev 2003;74:300-310.
11. Brandsma JW, Van Brakel WH, Anderson AM, Kortendijk AJ, Gurung KG, Sunwar SK. Intertester reliability of manual muscle strength testing in leprosy patients. Lepr Rev 1998:69:257-266.
12. Magora A, Sheshin J, Sagher F, Gonen B. The condition of the peripheral nerve in leprosy under various forms of treatment: conduction velocity studies in long-term follow-up. Int J Lepr 1970;38:149-163.
13. Naafs B, Dagne T. Sensory testing: a sensitive method in the follow-up of nerve involvement. Int J Lepr 1977;45:364-368.
14. Naafs B, van Droogenbroeck JBA. Décompression des névrites réactionnelles dans la lèpre: justificati on physio pathologi que et méthodes objectives pour en apprécier les résul tats. Med Trop 1977;37:763-770.
15. Brasil. Ministério da Saúde. Secretaria de Políticas de Saúde. Departamento de Atenção Básica. Guia para o controle da hanseníase. Brasília. (Cadernos de Atenção Básica n. 10, Série A: Normas e Manuais Técnicos, n .111). 2002.
16. Stump RNAG, Baccarelli R, Marciano LHSC, et al. Neuropathic pain in leprosy patients. Int J Lepr 2004;72:134-138.
17. Garbino JA, Opromolla DVA. Monitoração da neuropatia da hanseníase. In Opromolla DVA, Baccarelli R (eds). Prevenção de incapacidades e reabilitação em hanseníase. Bauru: ILSL; 2003:33-36.
18. Lehman LF, Orsini MBP, Nicholl ARJ. The development and adaptation of the Semmes-Weinstein monofilaments in Brazil. J Hand Ther 1993;6:290-299.
19. Stälberg E, Falck B. Motor nerve conduction study. Method Clin Neurophysiol 1993;4:61-80.
20. Naafs B. Treatment duration of reversal reaction: a reappraisal: back to the past. Lepr Rev 2003;74:328-336.
21. Foss NT, Souza CS, Goulart IMB, Gonçalves HS, Virmond M. Hanseníase: episódios reacionais. In Jatene FB, Cutait R, Cuce Nobre MR, Marques Bernardo W (eds). Projeto diretrizes. São Paulo: Associação Médica Brasileira. Conselho Federal de Medicina; 2003:161-179. Disponível em: http:// www.amb.org.br.
22. Lockwood DNJ. Steroids in leprosy Type 1 (reversal) reactions: mechanisms of action and effectiveness. Workshop proceedings: leprosy research at the new millennium. Lepr Rev 2000;71(Suppl):S111-S114.
23. Saunderson P. The epidemiology of reactions and nerve damage. Workshop proceedings. Leprosy research at the new millennium. Lepr Rev 2000;71(Suppl):S106-S110.
24. Van Brakel WH. Peripheral neuropathy in leprosy and its consequences. Workshop proceedings: leprosy research at the new millennium. Lepr Rev 2000;71(Suppl):S146-S153.
25. van Brakel WH. Peripheral neuropathy in leprosy: the continuing challenge. Utrecht: Universiteit Utrecht 1994.
26. Sundar Rao PSS, Sugumaran DST, Richard J, Smith WCS. Multi-centre, double blind, randomized trial of three steroid regimens in the treatment of type1 reactions in leprosy. Lepr Rev 2006;77:25-33.
27. Mahajan VK, Sharma NL, Sharma RC, Sharma A. Pulse dexamethason, oral steroids and azathioprine in the management of erythema nodosum. Lepr Rev 2003;74:171-174.
28. Schreuder P A M, Naafs B. Chronic recurrent ENL, steroid dependent: long-term treatment with high dose clofazimine. Lepr Rev 2003;74:386-388.
29. Richardus JH, Withington SG, Anderson AM, et al. Adverse events of standardized regimens of corticosteroids of prophylaxis and treatment of nerve function impairment in leprosy: results from the 'TRIPOD' trials. Lepr Rev 2003;74:319-327.